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X-Ray Structures of Myc-Max and Mad-Max
Recognizing DNA: Molecular Bases of Regulation
by Proto-Oncogenic Transcription Factors
1985; Schwab et al., 1984). Finally, it is thought that myc
genes are among the most frequently affected genes in
human tumors (Nesbit et al., 1999).
The full-length Myc gene product is a trans-acting,
DNA-binding regulator of transcription (Prendergast et
Satish K. Nair2 and Stephen K. Burley1,*
Laboratories of Molecular Biophysics
Howard Hughes Medical Institute
The Rockefeller University
1230 York Avenue
New York, New York 10021 al., 1991). All Myc isoforms contain two independently
functioning polypeptide chain regions: N-terminal trans-
activating residues and a C-terminal basic-helix-loop-
helix-leucine zipper (bHLHZ) segment (Figure 1A). TheSummary
bHLHZ domain specifies dimerization through the helix-
loop-helix-leucine zipper (HLHZ) region and DNA recog-X-ray structures of the basic/helix-loop-helix/leucine
nition via interactions between the basic (b) region andzipper (bHLHZ) domains of Myc-Max and Mad-Max
the major groove. Myc cannot form homodimers in vivo,heterodimers bound to their common DNA target (En-
at least at physiologic concentration, and does not sup-hancer or E box hexanucleotide, 5-CACGTG-3) have
port sequence-specific DNA binding in isolation.been determined at 1.9 A˚ and 2.0 A˚ resolution, respec-
A more complete understanding of Myc biologytively. E box recognition by these two structurally simi-
emerged following the discovery of a closely relatedlar transcription factor pairs determines whether a cell
bHLHZ protein, Max, which lacks an activation segmentwill divide and proliferate (Myc-Max) or differentiate
and serves as an obligate, physiological heterodimeriza-and become quiescent (Mad-Max). Deregulation of
tion partner for c-Myc (Blackwood and Eisenman, 1991;Myc has been implicated in the development of many
Prendergast et al., 1991). Myc function in transcriptionalhuman cancers, including Burkitt’s lymphoma, neuro-
activation, cellular transformation, and apoptosis re-blastomas, and small cell lung cancers. Both quasi-
quires heterodimerization of the Myc and Max bHLHZsymmetric heterodimers resemble the symmetric Max
regions prior to sequence-specific DNA binding. Myc-homodimer, albeit with marked structural differences
Max heterodimers recognize a core hexanucleotide ele-in the coiled-coil leucine zipper regions that explain
ment (5-CACGTG-3), termed the Enhancer box or Epreferential homo- and heteromeric dimerization of
box (Blackwood and Eisenman, 1991; Prendergast etthese three evolutionarily related DNA-binding pro-
al., 1991), and activate transcription at promoters con-teins. The Myc-Max heterodimer, but not its Mad-Max
taining such E boxes (Benvenisty et al., 1992; Eilers etcounterpart, dimerizes to form a bivalent heterotet-
al., 1991). Unlike Myc, Max can homodimerize and bindramer, which explains how Myc can upregulate ex-
E boxes. At present, the precise biological role(s) of thepression of genes with promoters bearing widely sep-
Max homodimer remain unknown, but there are sugges-arated E boxes.
tions that Max can function as a transcriptional repres-
sor (Kretzner et al., 1992). Sequence analyses of putative
Introduction Myc target genes and the results of in vitro binding
assays suggest that nucleotides flanking the E box ele-
Since the identification of the myc genes as transforming ment confer binding preferences for Myc-Max hetero-
agents within chicken retroviruses (Sheiness et al., dimers versus Max homodimers (Grandori and Eisen-
1978), compelling evidence has accumulated for their man, 1997; Grandori et al., 1996).
role in tumor formation both in experimental systems The bHLHZ region of Myc has also been implicated
and in human malignancies (Cole and McMahon, 1999; in interactions with various cellular factors, including
Dang et al., 1999; Eilers, 1999; Liao and Dickson, 2000; Nmi (Bao and Zervos, 1996), AP-2 (Gaubatz et al., 1995),
Nesbit et al., 1999). Oncogenic activity of Myc protein Brca1 (Wang et al., 1998), and Miz-1 (Peukert et al.,
is a direct result of deregulated expression and does 1997). Interaction of Myc-Max heterodimer with Miz-1
not require mutations within the open reading frame. has been validated but other reported interactions are
For example, in Burkitt’s lymphoma the coding region not well characterized. Each of these molecules regulate
for the cellular Myc (c-Myc) gene product is translocated gene expression, and their interactions with bHLHZ tran-
to heavy or light chain genes of immunoglobulin loci, scription factors appear to be limited to associations
leading to deregulated patterns of Myc protein expres-
with the bHLHZ region of Myc (Sakamuro and Prender-
sion (Dalla-Favera et al., 1982; Taub et al., 1982). Related
gast, 1999). Such higher order interactions document a
myc family genes, such as n-myc (neuroblastomas) and
role for Myc in targeting factors to particular promoter
l-myc (small lung cancer), are also amplified and/or de-
regions and suggest that the bHLHZ portions of the Myc-
regulated in malignancies (Kohl et al., 1983; Nau et al.,
Max heterodimer play an architectural role in stabilizing
nucleoprotein assemblies, such as enchanceosomes
*Correspondence: stephen_burley@stromix.com (Carey, 1998; Merika and Thanos, 2001).
1Present Address: Structural GenomiX, Inc., 10505 Roselle Street, Soon after the discovery of Max, a second class of
San Diego, California 92121.
bHLHZ proteins, including Mad1 (Ayer et al., 1993) and2 Present Address: Department of Biochemistry and Center for Bio-
Mxi1 (Zervos et al., 1993) were independently shown tophysics and Computational Biology, University of Illinois at Urbana-
Champaign, 600 South Mathews Avenue, Urbana, Illinois 61801. heterodimerize with Max and recognize E boxes. Subse-
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Figure 1. Myc, Max, and Mad Primary Sequences, Crystallization Oligonucleotides, and Semisynthetic Scheme for Chemoselective Ligation
(A) Partial sequence alignment of the DNA binding domains of human cMyc protein with the bHLHZ proteins Max, Mad, nMyc, lMyc, USF,
E47, MyoD, and Pho4. Secondary structure assignments are based on X-ray crystal structures (where available) and conserved residues are
highlighted in red.
(B) Sequence of the duplex oligonucleotides used in crystallization with Myc-Max (upper) and Mad-Max (lower). Positions of 5-iodo-dUra
substitutions for heavy atom derivatives are denoted with an asterisk (*).
(C) Semisynthetic scheme used for the production of chemoselectively ligated Myc-Max and Mad-Max heterodimers (Experimental Procedures).
quent identification and characterization of Mad1 para- tional repression by the Mad-Max heterodimer emerged
after identification of interactions between Mad andlogs demonstrated similar functions (Hurlin et al., 1994).
High levels of mad mRNA and Mad protein are found in mSin3, a corepressor (Ayer et al., 1995; Schreiber-Agus
et al., 1995). Mad-Max heterodimers recruit mSin3 core-growth arrested, differentiated cells in which c-Myc is
not expressed. Moreover, Mad protein inhibits cell pressors to promoter DNA, which leads to recruitment
of histone deacetylases, condensation of chromatingrowth and interferes with the transforming function of
Myc, demonstrating that Mad-Max is a transcriptional structure, and reduced transcription levels (Hassig et
al., 1997; Laherty et al., 1997). Conversely, the ATM-repressor (Hurlin et al., 1994; Larsson et al., 1997, 1994;
McArthur et al., 1998). related c-Myc binding protein TRRAP interacts with
Myc-Max heterodimers to mediate recruitment of his-Further advances in our understanding of transcrip-
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195
tone acetyltransferases and upregulation of gene ex- terminus of Max, which enables chemoselective ligation
with C-terminal Cys forms of either Myc or Mad.) Incuba-pression (Cole and McMahon, 1999; McMahon et al.,
2000; Saleh et al., 1998). Thus, competition between tion of Myc-Gly-Gly-Cys (or Mad-Gly-Gly-Cys) with the
Max-pyridylsulfenyl-cysteine adduct under denaturingMyc-Max and Mad-Max heterodimers for common DNA
targets appears to control cell fate, determining the conditions lead to thiolysis of the (2-pyridylsulfenyl)-
cysteine by the C-terminal Cys of Myc (or Mad), resultingchoice between proliferation/transformation and differ-
entiation/quiescence. in highly efficient formation of directed disulfide-linked
heterodimers (Figure 1C). Each heterodimer was thenThe X-ray structure of the Max homodimer bound
to an E box, derived from the Adenovirus major late refolded and further purified using standard methods
(Experimental Procedures). Analytical reverse phasepromoter, established the structural bases for DNA rec-
ognition by bHLHZ proteins (Ferre-D’Amare et al., 1993). HPLC and electrospray ionization mass spectrometry
(ESI-MS) were used to identify all reaction intermediatesOur cocrystal structure revealed that Max dimerizes to
form an asymmetric, parallel left-handed four-helix bun- and confirm that we had obtained the desired hetero-
dimeric products. Electrophoretic mobility shift assaysdle composed of two pairs of right-handed  helices
(b-H1 and H2-Z). The basic region projects from the (EMSA) with E box containing oligonucleotides demon-
strated high affinity, specific DNA-binding activity forN-terminal face of the four-helix bundle and interacts
with DNA via sequence-specifying contacts with the the chemoselectively ligated Myc-Max and Mad-Max
heterodimers, which compared favorably to the DNA-major groove edges of base pairs comprising the E box.
C-terminal extensions of two  helices form a left- binding properties of native, unligated Max, and disul-
fide-linked Max homodimers (data not shown).handed coiled-coil or leucine zipper. More recently pub-
lished X-ray studies of a related protein involved in regu-
lation of cholesterol levels in humans (SREBP1; Parraga Crystallization and Structure Determination
et al., 1998) documented that the structure of the bHLHZ Reconstituted heterodimers were mixed with a stoichio-
dimer is essentially identical among bHLHZ family metric excess of oligonucleotide, and the desired pro-
members. tein-DNA complexes were purified by size exclusion
In this paper, we report cocrystal structures of chemo- chromatography and subject to crystallization trials.
selectively ligated c-Myc-Max (hereafter Myc-Max) and Twenty-three different C- and/or N-terminal truncations
Mad1-Max (hereafter Mad-Max) heterodimers bound to of the Myc and Max bHLHZ domains and over two hun-
duplex oligonucleotides containing E boxes. Although dred duplex oligonucleotides were screened before dif-
both heterodimers resemble the Max homodimer (Brown- fraction quality cocrystals were obtained (Experimental
lie et al., 1997; Ferre-D’Amare et al., 1993), marked differ- Procedures). The proteins used for structure determina-
ences exist within the leucine zipper regions. Site- tion encompass human Myc residues 353–434 (hereafter
directed mutagenesis combined with protein-protein Myc), Max residues 22–103 (hereafter Max), and Mad
interaction assays documented that these structural dif- residues 55–136 (hereafter Mad).
ferences account for preferential heterodimer formation Experimental phases for the Myc-Max heterodimer
among Myc, Mad, and Max. Within our Myc-Max cocrys- cocrystal structure were determined at 2.8 A˚ resolution
tals, two heterodimers associate tightly to form a biva- using three halogenated-DNA heavy atom derivatives.
lent heterotetramer that explains previously published Our previously determined Max cocrystal structure
biochemical observations. The biological significance (Ferre-D’Amare et al., 1993) was positioned in the experi-
of Myc-Max oligomerization is discussed in the context mental electron density using a brute force phased
of our cocrystal structures. translation search (B. Strokopytov and S. Almo, personal
communication) and the quality of the experimental
phases was improved by non-crystallographic symme-Results and Discussion
try averaging and phase extension to 1.9 A˚ resolution
(Experimental Procedures). The cocrystal structure ofFormation of Covalent Myc-Max and Mad-Max
the Mad-Max heterodimer was determined via molecu-Heterodimers Via Chemoselective Ligation
lar replacement, using the structure of the Myc-MaxStructural and biophysical characterization of Myc-Max
heterodimer as a search model, and refined to 2.0 A˚and Mad-Max heterodimers was complicated by Max
resolution. A summary of the crystallographic analysesprotein homodimerization at high concentrations (i.e.,
is provided in Table 1.0.1–1 mM). To overcome this problem and increase the
likelihood of successful crystallization trials, a semisyn-
thetic strategy (Baca et al., 1995) was used to produce Structure of the Myc-Max and Mad-Max
bHLHZ Heterodimerspure preparations of chemoselectively ligated Myc-Max
and Mad-Max heterodimers. Minimal bHLHZ domains Three-dimensional structures of the Myc-Max and Mad-
Max heterodimers are illustrated in Figure 2. Theseof c-Myc (Watson et al., 1983; Watt et al., 1983), Max
(Blackwood and Eisenman, 1991), and Mad1 (Ayer et structures recapitulate the disposition of secondary
structural elements observed in our cocrystal structuresal., 1993), each bearing a Gly-Gly linker followed by a
Cys at their C-termini (Figure 1A), were expressed in of the Max and SREBP1 homodimers (Ferre-D’Amare
et al., 1993; Parraga et al., 1998). Each half of the hetero-E. coli. The sulfhydryl group in Max-Gly-Gly-Cys was
derivatized with 2,2-dipyridyl disulfide, and the re- dimer consists of two long  helices separated by a
short random coil loop region (L). The N-terminal  helixsulting Max-pyridylsulfenyl cysteine adduct was purified
from unmodified protein by reverse phase HPLC. (This represents a continuous secondary structural element
encompassing both the basic region (b) and  helixstep adds a leaving group to the Cys residue at the C
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Table 1. Statistics of Crystallographic Analysis
Phasing powerMyc-Max Wavelength Resolution Reflections (%) Completeness Rsym # Sites
Data set Beamline (A˚) (A˚) (total/unique) (total/outer shell) (%) (total/unique) Iso Ano
Native 1 NSLS-X9A 0.92 2.3 134,509/25,186 96.5/90.6 5.2 – – –
Iodo 1 NSLS-X9A 1.54 2.5 57,481/18,071 93.1/91.1 5.6 8/8 2.4 1.9
Iodo 2 NSLS-X9A 1.54 2.5 103,200/17,699 90.5/88.4 6.4 8/4 1.0 0.7
Iodo 3 NSLS-X9A 1.54 2.7 61,374/11,919 76.4/58.7 5.8 4/0 1.1 –
Native 2 APS-19ID 0.91 1.8 276,421/49,228 95.9/90.9 5.3 – – –
Refinement against Native 2
Resolution (A˚) 20–1.8
Number of atoms
Proteins 2759
DNA 1540
Solvent 581
Rcryst/Rfree (%) 21.9/26.3
RMSD bond length (A˚) 0.005
RMSD bond angles () 0.95
Mad-Max Wavelength Resolution Reflections (%) Completeness Rsym
Data set Beamline (A˚) (A˚) (tot./unique) (tot./outer shell) (%)
Native 1 NSLS-X25 0.92 2.0 214,612/35,483 88.8/59.9 5.2
Refinement
Resolution (A˚) 20–2.0
Number of atoms
Proteins 2509
DNA 1467
Solvent 251
Rcryst/Rfree (%) 26.4/32.4
RMSD bond length (A˚) 0.006
RMSD bond angles () 0.94
Rsym  |I  I|I, where I is the observed intensity and I is the average obtained from multiple observations of symmetry related
reflections.
Phasing power  rmsd (FH/E), where FH  heavy atom structure factor amplitude and E  residual lack of closure.
Rcryst  ||Fobserved|  |Fcalculated||/|Fobserved|, Rfree  Rcryst calculated using 10% random data omitted from the refinement.
Figure 2. Structures of Myc-Max and Mad-Max Heterodimers Bound to DNA
Molscript (Kraulis, 1991)/Raster3D (Merritt and Murphy, 1994) drawing showing the overall topology of the Myc-Max/DNA (A) and Mad-Max
(B) cocrystal structures. Color coding: Myc-cyan, Max-red, and Mad-green. Cocrystallization oligonucleotide is shown as an atomic stick
figure. The helix, basic region, and zipper regions have been designated on the Myc-Max/DNA structure.
Cocrystal Structures of Myc-Max and Mad-Max
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Figure 3. Comparison of Homo- and Hetero-
dimeric bHLHZ Complexes
(A) Ribbon diagram of the Max homodimer
(red), showing the C-terminal region of the
leucine zipper. Residues comprising the
Gln91-Asn92-Gln91*-Asn92* tetrad at the in-
termolecular interface are shown as atomic
stick figures.
(B) GRASP (Nicholls et al., 1991) representa-
tion of the molecular surface of the Max ho-
modimer showing bulging of the  helices
with the resulting packing defect, viewed as
in Figure 3A.
(C) Ribbon diagram of the Myc-Max hetero-
dimer (Myc-blue; Max-red), viewed as in Fig-
ure 3A. Hydrogen bond pairs created by the
disposition of Gln-Asn-Arg-Arg residues in
the tetrad region yield a tighter dimer in-
terface.
(D) Least squares superposition of the  car-
bon coordinates of the Max homodimer with
the Myc-Max heterodimer (Myc-blue; Max-
red) demonstrates that the leucine zipper re-
gions of these crystal structures deviate sig-
nificantly in the vicinity of the region of the
Gln-Asn tetrad in the Max homodimer.
(E) Ribbon diagram of the Mad-Max hetero-
dimer (Mad-green; Max-red), viewed as in
Figure 3A. The Gln-Asn-Glu-Gln tetrad forms
a tight dimer interface.
(F) Least squares superposition of the  carbon
atomic coordinates of the Max homodimer with
the Mad-Max heterodimer (Mad-green; Max-
red), showing the same phenomenon as illus-
trated in Figure 3D.
H1. The C-terminal  helix is also comprised of two and creation of a packing defect within the interface
(Figure 3B).continuous -helical segments, H2 and the leucine zip-
per (Z). In marked contrast, the leucine zipper regions of the
Myc-Max (Figures 3C and 3D) and Mad-Max (Figures
3E and 3F) heterodimers closely resemble the coiledTwo Leucine Zipper Residues Specify
coils found in GCN4 homodimers (Ellenberger et al.,Heterodimerization with Max
1992; O’Shea et al., 1991). Least squares superpositionsThe bHLHZ segments of Myc and Max, or Mad and Max,
of the  carbon coordinates of the Max homodimer withform quasisymmetric heterodimers that are stabilized
each heterodimer demonstrate that the leucine zipperby hydrophobic and polar interactions involving  heli-
regions of the heterodimers only deviate significantly inces H1, H2, and the leucine zipper region (Z). These
the vicinity of the Max-Max Gln91-Asn92-Gln91*-Asn92*extensive interfaces (buried solvent-accessible surface
tetrad (* denotes dimeric partner; root-mean-square de-areas: Myc-Max  3206 A˚2, Mad-Max  2970 A˚2 ) are
viations or rmsds: Myc-Max versus Max-Max  1.5 A˚,predominantly hydrophobic, with additional intermolec-
Mad-Max versus Max-Max  1.6 A˚, Myc-Max versusular contacts coming from hydrogen bonds along the
Mad-Max  1.6 A˚). In the Myc polypeptide chain, twoperiphery of the leucine zipper. Much of this coiled coil
positively charged residues (Arg423-Arg424) occupyresembles GCN4 homodimer (Ellenberger et al., 1992;
this position yielding an Arg423-Arg424-Gln91-Asn92O’Shea et al., 1991), and consists of a heptad repeat
tetrad within the Myc-Max heterodimer (Figure 3C). The(abcdefg) with hydrophobic residues at positions a and
hydrogen bond pairs mediated by these polar residuesd. In our Max homodimer structure, however, a Gln91-
yield a more intimate dimer interface and result in tighterAsn92-Gln91-Asn92 tetrad occurs near the C-terminal
intermolecular packing (Figure 3D). A similar situationend of the zipper region, with Gln91 at position g of one
pertains to the Mad-Max heterodimer, with Glu125 ofheptad and Asn92 at position a of the following heptad
Mad and Asn92 of Max forming a hydrogen bond (OE2-(Figure 3A). This packing scheme alters the trajectories
ND2  2.79 A˚; Figures 3E and 3F).of the two  helices making up the coiled coil, which is
manifested by flaring of the leucine zipper (Figure 3A) Conclusive identification of dimer specificity determi-
Cell
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Figure 4. Homo- and Heterodimerization As-
says with Myc and Max Tetrad Mutants
(A) Coomassie blue-stained SDS/PAGE gel of
GST-affinity assays showing lack of binding
of wild-type Myc or wild-type Max to GST
alone (lanes 1 and 2), lack of binding of wild-
type Myc to GST-Myc (lane 3) and binding of
wild-type Max to GST-Max (lane 4).
(B) Coomassie blue-stained SDS/PAGE gel of
GST-affinity assays shows binding of wild-
type Max to wild-type Myc (lanes 2 and 3),
Myc (Arg423→Gln) (lane 4), Myc (Arg423→
Gln/Arg424→Asn) (lane 5) and binding of Max
(Gln91→Arg/Asn92→Arg) to wild-type Myc
(lane 6) and Myc (Arg423→Gln/Arg424→Asn)
(lane 7).
nants within the Myc family was provided by a series ing can be explained by Coulomb repulsion of posi-
tively charged guanidium groups of the mutant Maxof single and double-mutant variations of tetrad pairing
that generate mutant homo- and heterodimers encom- (Gln91→Arg/Asn92→Arg) by the naturally occurring
Arg423/Arg424 pair in wild-type Myc. As predicted, thispassing every possible exchange permutation between
Myc and Max. Mutant proteins were purified to homoge- mutant form of Max does form a stable heterodimer with
the Myc mutant (Arg423→Gln/Arg424→Asn), becauseneity and characterized by GST-mediated pull-down
assays (Figure 4). As expected, wild-type Max interacts the hydrogen bonds observed in the wild-type Myc-Max
heterodimer are restored by this set of double mutants,stably with both itself and with wild-type Myc, and re-
placement of Arg423 of Myc with Gln does not preclude albeit in opposite orientation.
These results imply that homo- and heterodimeriza-heterodimerization with Max. Furthermore, the Myc dou-
ble mutant (Arg423→Gln/Arg424→Asn), which recapitu- tion specificity and avidity of Myc for Max are solely
mediated by the identities of the amino acids at positionslates the tetrad observed in the Max homodimer, also
interacts with wild-type Max. In contrast, a double- 91 and 92 (Max numbering). Not surprisingly, the charge-
neutral Gln91-Asn92-Gln91*-Asn92* tetrad can supportmutant form of Max (Gln91→Arg/Asn92→Arg) exhibited
no detectable interaction with wild-type Myc. This find- Max homodimerization, whereas the tetrad of positively
Cocrystal Structures of Myc-Max and Mad-Max
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charged guanidium groups (Arg423-Arg424-Arg423*- two residues within the loop region of Myc make non-
specific hydrogen bond contacts: NZ of Lys371 withArg424*) disfavors Myc homodimerization. Myc-Max
heterodimerization is favored over Max homodimeriza- O1P of Ada(2) (3.2 A˚) and NZ of Lys 392 with O1P of
Ada(2) (2.9 A˚). Combinatorial solid-phase peptide syn-tion by disposition of complementary polar residues at
these positions within Myc and Max resulting in hydro- thesis and DNA affinity studies by Winston and Gottes-
feld have identified the role of loop residues of bHLHgen bond pairing within the heterodimer interface.
It is remarkable that Mad-Max heterodimerization ap- proteins in contributing to DNA-binding (Winston and
Gottesfeld, 2000).pears to be controlled by the identity of a single interfa-
cial amino acid (Glu125). Model building studies with Site-directed mutagenesis and basic region swap ex-
periments between Myc and Max have suggested thatmutant forms of Mad suggest that the hetero- and homo-
dimerization properties of Mad can be similarly manipu- the Myc and Mad proteins are not functionally equivalent
and have separable E box binding activities (O’Hagan etlated by modifying Glu125 and Gln126 (data not shown).
Mad residue Glu125 establishes a network of comple- al., 2000). Specifically, mutation of Myc residue Arg357
supports a role for this residue in oncogenic potency.mentary hydrogen bond interactions at the tetrad inter-
face that supports heterodimerization with Max. Glu125 Within our crystal structure, Arg357 is faces away from
the DNA and is not involved in direct interactions withOE2 engages ND2 of Max residue Asn92* (2.79 A˚). In
turn, OD1 of Asn92* hydrogen bonds to NE2 of Gln126 the E box or flanking nucleotides. As suggested by the
authors, it is conceivable that the observed effects of(3.29 A˚), which, itself, hydrogen bonds to OE1 of Gln 91*
(3.07 A˚). mutation at Arg357 at the Myc basic region may be
mediated by inter- or intramolecular interactions with
other proteins, but these suggestions have yet to beStructural Basis of E Box Recognition
experimentally confirmed.In order to avoid the effects of twofold averaging of the
oligonucleotide about the internal pseudo dyad imposed
by the palindromic E box, we used a symmetric oligonu- Crystal Structure Reveals a Bivalent
Myc-Max Heterotetrametercleotide for our cocrystallization experiments. In both
of our heterodimer cocrystal structures, the DNA adopts The two Myc-Max/DNA complexes constituting the
asymmetric unit in our cocrystals are related by a non-a modified B form conformation, characterized by a
narrowed major groove and a widened minor groove crystallographic 2-fold rotation. The most remarkable
feature of this intimate dimer of heterodimers is the(Nekludov and Pabo, 1994). There is no evidence of
DNA bending in contrast to a cocrystal structure of Max head-to-tail assembly of the individual leucine zippers
of each heterodimer, resulting in formation of an antipar-homodimer (Brownlie et al., 1997) and gel mobility and
phasing analysis studies that were interpreted to show allel four-helix bundle (Figure 5A). This four-helical bun-
dle is topologically similar to helical bundles observeda bend of up to 80 toward the minor groove (Fisher et
al., 1992). in members of the cytokine family and in leukemia inhibi-
tory protein (Hill et al., 1993; Somers et al., 1997; Rob-The cocrystal structures of the Myc-Max and Mad-
Max heterodimers bind to their respective DNA targets inson et al., 1994).
Salt bridges and hydrogen bonds, burying nearlywith each component of the heterodimer interacting with
half of the 5-CACGTG-3 recognition site. Myc, Max, 1400 A˚2 of solvent-accessible surface area, mediate
packing interactions between the two heterodimers (Fig-and Mad use essentially identical protein-DNA contacts
for recognition of the E box to those detected in our ure 5B). Within this head to tail arrangement of leucine
zippers, Max residue Lys77 from one heterodimer inter-Max homodimer structure (Ferre-D’Amare et al., 1993).
Four sequence-specifying contacts are made between acts with Glu432# (# denotes second heterodimer of biva-
lent tetramer) of Myc from the second heterodimer (NZ-each basic region and selected DNA bases within the
recognition sequence 5-Cyt(1)-Ade(2)-Cyt(3)-Gua(4)- OE2 2.6 A˚) and is situated near the backbone carbonyl
oxygens of Lys428# and His429#. Myc residue Glu425#Thy(5)-Gua(6)-3, including NE2 of His28 (Myc: His359;
Mad: His61) and N7 of Gua(3), where ’ denotes opposite is situated within a positively charged region within the
tetramer interface comprising Max residues Lys77 (OE1-strand (see Figure 1), OE1 of Glu32 (Myc: Glu363; Mad:
Glu65) with N4 of Cyt(3) and OE2 of Glu32 with N6 of NZ  4.1 A˚) and His-81 (OE1-NE2  3.8 A˚), which, in
turn, faces toward the backbone carbonyls of Lys423#Ade(2), and NH1 of Arg36 (Myc: Arg-367; Mad: Arg69)
with N7 of Gua(1’). The contact made by Arg36 dictates and Glu425#. Myc residue Glu417# makes polar contacts
with Myc residues Arg-424 and Arg421 from the secondthe identity of the central 5-CG-3 dinucleotide and
distinguishes bHLHZ proteins that bind class A E box heterodimer and Arg424 faces toward Max residue
Asp84#.elements from those that bind the non-canonical class
B site (5-CAGCTC-3), such as AP4 (Dang et al., 1992). Previously published in vivo and in vitro studies have
shown that Myc-Max heterodimers can form higher or-A single amino acid substitution (Arg36→Met) suffices
to convert AP4 into a canonical class A E box binding der oligomers. Solution studies (Dang et al., 1989) by
Dang and coworkers demonstrated that Myc-Max is ca-protein (Dang et al., 1992).
Several additional contacts are observed between pable of forming bivalent heterotetramers and that tetra-
merization depends on Myc leucine zipper region. Sev-residues specific to Myc and the phosphate backbone:
NZ of Lys355 forms hydrogen bonds with both phos- eral lines of evidence suggest that the bivalent
heterotetramer observed in our Myc-Max cocrystals ex-phate oxygens of Gua(-4) (NZ-O1P  3.6 A˚: NZ-O2P 
3.3 A˚), Arg356 hydrogen bonds with backbone phos- ists under physiological conditions. First, solution ex-
periments demonstrated that the Myc-Max heterodimerphate oxygen of Thy(5) (NH1-O2P  2.7 A˚). In addition,
Cell
200
Figure 5. Bivalent Myc-Max Heterotetramer
(A) Ribbon diagrams of the bivalent Myc-Max heterotetramer observed in the Myc-Max/DNA cocrystals.
(B) GRASP (Nicholls et al., 1991) molecular surface rendition of one heterodimer with  carbon backbone representation (cyan and red) of
the other. The view is orthogonal to the orientation in Figure 5A. Salt bridges and hydrogen bonds, burying nearly 1400 A˚2 of solvent-accessible
surface area, mediate packing interactions between the two heterodimers. The polarity of many of the residues in Myc that comprise this
interaction network is altered in Mad and this alteration in polarity of the residues that stabilize the interaction of the Myc-Max heterotetramer
may explain the lack of tetramer formation by Mad-Max heterodimers.
(C) Size exclusion profile of the Myc-Max heterodimer. Approximately, 300 M of the heterodimer was loaded onto a Superdex 75 column
(Pharmacia) and representative fractions from the elution run are shown on a Coomassie blue-stained SDS/PAGE gel. Elution volumes for
four calibration standards are noted on the chromatogram. Myc-Max elutes at a position corresponding to a relative molecular mass of
approximately 40 kDa corresponding to the expected size of the Myc-Max heterotetramer observed in the crystals.
(D) Hydrodynamic characterization of the Myc-Max bivalent heterotetramer. Sedimentation equilibrium data were collected at 280 nm with a
rotor speed of 20,000 rpm at a temperature of 20C using a Beckman XL-A ultracentrifuge. The fit corresponds to a two-component model
with a tethered Myc-Max dimer to Myc-Max tetramer association constants of 90 nM. The residuals of the fit are shown in the lower image.
Data analysis utilized the NONLIN program (http://www.cauma.uthscsa.edu/software).
can form a tetramer at sub-molar concentrations (Fig- 6,300 c-Myc molecules in MRC5 fibroblasts as deter-
mined by enzyme-linked immunosorbent assay (Mooreure 5C) and analytical ultracentrifugation studies re-
vealed a tetramer-dimer equilibrium dissociation con- et al., 1987) or 29,000 c-Myc molecules for IMR90 fibro-
blasts as determined by quantitative Western blottingstant of 90 nM (Figure 5D). Published quantitative
analyses of c-Myc copies per proliferating cells estimate (Rudolph et al., 1999). Assuming a homogenous distribu-
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tion of c-Myc molecules within a spherical nucleus with Max heterodimer. Interestingly, the polarity of many of
a diameter of 5.0 M, these estimates correspond to the residues in Myc that comprise the interaction net-
nuclear c-Myc concentrations of 152 nM (for MRC5 fi- work in the Myc-Max heterotetramer is altered in Mad.
broblasts) or 764 nM (for IMR90 fibroblasts). Given that For example, Myc residue Glu425 is Arg127 in Mad,
our measured dissociation constant of 90 nM is lower Arg423 of Myc is Glu125 in Mad, and His429 of Myc is
than either of the two estimates of physiological c-Myc Arg131 in Mad. Conceivably, this alteration in polarity
levels, our data conclusively document that c-Myc-Max of the residues that stabilize the interaction of the Myc-
exists as a bivalent heterotetramer at physiologic con- Max heterotetramer may explain the lack of tetramer
centrations. Second, solvent-accessible surface area formation by Mad-Max heterodimers in solution and in
burial on bivalent heterotetramer formation is 1375 A˚2, our cocrystals. It is possible that assembly of Myc-Max
which is well in excess of the accepted upper limit of into bivalent heterotetramers allows for cooperative reg-
600 A˚2 for adventitious lattice-packing contacts (Janin, ulation at promoters and enhancers containing multiple
1997). Finally, electron microscopic studies with syn- E boxes.
thetic myc promoters containing multiple E-boxes sepa-
rated by distances of 100–200 nucleotides demon- Comparison with Long-Range Interactions Observed
strated that the Myc-Max heterodimer can engage in c-Myb-C/EBP Cocrystal Structure
spatially disparate E box binding sites, presumably via The bivalent assembly of Myc-Max heterodimers ob-
higher order oligomerization (T. Haggerty, and C.V. served in our cocrystal structure recapitulates many
Dang, personal communication). structural elements found in the c-Myb-C/EBP	 cocrys-
The biological relevance of the bivalent heterotet- tal structure (Tahirov et al., 2002). The DNA binding do-
ramer observed in our Myc-Max cocrystals is borne out mains of c-Myb and C/EBP	 interact in a head on fashion
by a wealth of genetic and biochemical data. Work from allowing for cooperative interaction, despite the fact that
a number of laboratories has shown that Myc-Max can the individual proteins bind to widely separated sites on
recruit various cellular factors, most convincingly Miz-1 natural promoters. Atomic force microscopic studies,
(Peukert et al., 1997) but also including Nmi (Bao and utilizing a synthetic promoter containing cognate recog-
Zervos, 1996), AP-2 (Gaubatz et al., 1995), and Brca1 nition sites separated by 82 nucleotides, documented
(Wang et al., 1998). Each of these higher order assem- that the observed long-range interaction is mediated
blies result from specific interactions with the bHLHZ by DNA looping. This assembly of individual proteins
region of Myc (Sakamuro and Prendergast, 1999). Given components in the c-Myb-C/EBP	 cocrystal structure
that all of these proteins are transcription factors, which is analogous to dimerization of Myc-Max heterodimers
are recruited to specific regions of the promoter, it to form the bivalent heterotetramer observed in our co-
seems reasonable to suggest that the bHLHZ regions crystal structure. The carboxy-terminal coiled-coil of the
of the Myc-Max heterodimer play an architectural role. C/EBP	 leucine zipper interacts with two  helices
Formation of the bivalent heterotetramer observed in within c-Myb to form a four-helix bundle similar to the
our cocrystal structure would provide a substantial plat- four-helix bundle that stabilizes the Myc-Max heterotet-
form for assembly of additional protein factors. ramer. v-Myb, which differs from c-Myb in the interfacial
Genetic characterization of the promoters of putative
 helices, does not form a productive complex with
myc regulated genes has provided further evidence for C/EBP	. The C/EBP family of proteins has a leucine
a physiological role for Myc-Max heterotetramerization. zipper that is extended by one heptad repeat that under-
Oligonucleotide microarray analysis has identified sev- goes a coil-to-helix transition upon binding to c-Myb
eral Myc target genes that contain multiple E boxes
(Tahirov et al., 2002).
within promoters, typically separated by at least 100
The carboxy-terminal regions of C/EBP	 chains A and
nucleotides (Coller et al., 2000; see also Grandori and
B form a polar interaction network with the exposed Eisenman, 1997). Given the persistence length of DNA,
helices of c-Myb (-1 and -2). A network of directionalthis separation of Myc-Max binding sites is compatible
polar interactions (salt bridges and hydrogen bonds), arewith DNA looping stabilized by bivalent Myc-Max het-
observed in the interface between c-Myb and C/EBP	,erotetramers bound to two cognate sequences. More-
where they appear to specify this particular binary com-over, in vitro binding studies of Myc-Max heterodimers
plex. A similar network of salt bridges and hydrogenrecognizing the lactate dehydrogenase gene, a natural
bonds specify the formation of the Myc-Max bivalenthigh-affinity target containing two consensus E boxes
tetramer (see previous section for details). The solvent-(Shim et al., 1997), demonstrates that Myc-Max com-
accessible surface area buried between C/EBP	 andplexes can engage multiple cognate sites. Functional
c-Myb is 1438 A˚ and is comparable to the estimatedstudies with adjacent E boxes found within the lactate
1375 A˚ buried upon formation of the bivalent Myc-Maxdehydrogenase promoter showed that mutations in ei-
tetramer. Interactions among transcriptional factorsther of the two E boxes severely affect Myc-dependent
bound to widely separated sites may be a general mech-activation of transcription (T. Haggerty, and C.V. Dang,
anism for the assembly of large nuclear complexes suchpersonal communication). These results suggest that
as enhanceosomes (Carey, 1998; Merika and Thanos,Myc-Max complexes can form higher order structures
2001).that are consistent with the heterotetrameric assembly
observed in our cocrystal structure.
ConclusionAn extensive network of hydrogen bonds and salt
bridges mediates the protein-protein interface stabiliz-
The cocrystal structures of the Myc-Max and Mad-Maxing the Myc-Max heterotetramer. Residues comprising
this polar interaction network are unique to the Myc- heterodimers recognizing their E box targets demon-
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These crystals also grew in the triclinic space group P1 (a  47.4 A˚,strate how bHLHZ heterodimers can mediate specific,
b  56.0 A˚, c  65.6 A˚,   88.8, 	  79.1, 
  67.1). Anisotropichigh-affinity DNA binding. Our structures and comple-
diffraction was observed to 1.9 A˚ resolution at best, and 2.2 A˚mentary biochemical findings suggest that two residues
resolution elsewhere in the diffraction pattern.
located within the C-termini of the leucine zipper regions
are largely responsible for bHLHZ domains hetero-
Data Collection, Structure Determination, and Refinementdimerization by Myc and Mad with Max. The crystal
Native and heavy atom derivative diffraction data were collectedstructure of the Myc-Max complex explains why this
using various synchrotron beamlines under standard cryogenic con-
heterodimer, and only this heterodimer, can form a biva- ditions. Data were processed using DENZO and SCALEPACK (Otwi-
lent heterotetramer. Tetramerization of Myc and Max nowski, 1997). Structure determination was carried out with a 95.2%
complete, 3-fold redundant native data set, with an overall Rsym(I) is mediated by extensive protein-protein interactions
5.3% (20–2.3 A˚ resolution). Heavy atom derivative data were typicallybetween leucine zipper domains, and the resulting anti-
obtained at a maximum resolution limits between 2.8–2.5 A˚. Experi-parallel four-helix bundle could provide a scaffold for
mental phases were estimated at 2.8 A˚ resolution using SHARP,recruitment of additional modulators of transcription.
giving an overall figure of merit of 0.54 for acentric reflections. The
Finally, our structures also provide a starting point for resulting map was of poor quality despite reasonable phasing statis-
further directed biochemical and genetic studies to elu- tics, presumably due to heavy atom sites common to different heavy
atom derivatives. The |Fobserved|/(SHARP) electron density mapcidate the roles played by Myc-Max and Mad-Max in
was improved with density modification/histogram matching andcell fate determination.
the resulting phases (15–3.5 A˚ resolution) were used for brute force
phased/rotation translation search (B. Strokopytov and S. Almo,
personal communication) with X-PLOR (Bru¨nger, 1992).Experimental Procedures
A bHLHZ search model was generated from our structure of the
Max homodimer, with one protomer converted to polyalanine andProtein and DNA Preparation and Crystallization
DNA fragment encoding the minimal bHLHZ regions of human Myc both loop regions deleted, plus a minimal duplex DNA fragment
encompassing only the E box hexanucleotide. The initial phased/(residues 353–434), Max (residues 22–103), and Mad (residues 55–
136) were amplified from corresponding full-length cDNAs and sub- rotation translation search yielded two significant solutions ar-
ranged as stacked bHLHZ dimers, which proved to be the twocloned into a T7 RNA polymerase-dependent expression vector,
which also produces an N-terminal polyhistidine tag and a C-ter- copies of the Myc-Max heterodimer comprising the bivalent hetero-
tetramer (Figure 3C). These two solutions were then used to defineminal Gly-Gly-Cys tripeptide. (All other Cys residues within the
bHLHZ portions of these proteins were changed to Ser.) Both Myc the operators for 2-fold noncrystallographic symmetry averaging
and phase extension to 2.5 A˚, which yielded significant improve-and Mad were purified from inclusion bodies by nickel-ion affinity
chromatography under denaturing conditions. Max was purified us- ments in the quality of the electron density map. Interpretable elec-
tron density corresponding to regions of the protein that were noting standard chromatographic methods as previously described
(Ferre-D’Amare et al., 1993). present in the initial search model and the entire DNA were readily
discernible in this stage in structure determination.The reactive sulfhydryl group in Max-Gly-Gly-Cys was derivatized
with 2,2-dipyridyl disulfide, yielding a Max-pyridylsulfenyl cysteine Structure refinement was carried out with a 95% complete, 4-fold
redundant data set with an overall Rsym(I)  5.3% (20–1.8 A˚ resolu-adduct (Baca et al., 1995). The reaction product was purified from
unreacted starting material with a Vydac C4 semi-preparative HPLC tion). Several rounds of iterative model building and refinement were
performed using O (Jones et al., 1991) and CNS (Bru¨nger et al.,column using an acetonitrile gradient. The purified adduct was ly-
ophilized and stored under anaerobic conditions. Chemoselective 1998). The final model consists of two heterodimer-DNA complexes
and 581 water molecules, giving an R-factor of 21.9% with R-free ligation of the Myc-Max heterodimer was performed by mixing equi-
molar quantities of Max-(2-pyridylsulfenyl) dissolved in 6 M guani- 26.3%, and rmsds for bond lengths and angles of 0.005 A˚ and 0.95,
respectively. The mean thermal factors are 30 A˚2 for Myc and Max,dine-HCl with Myc-Gly-Gly-Cys and stirred at 4C. Thiolysis of the
Max-(2-pyridylsulfenyl) and formation of the desired chemoselec- 29 A˚2 for DNA, and 26 A˚2 for solvent molecules. PROCHECK (Laskow-
ski et al., 1993) revealed five ( 1.6%) unfavorable (φ,) combi-tively ligated Myc-Max heterodimer was monitored by reverse-
phase HPLC using a Vydac analytical C8 column and ESI-MS. Typi- nations in the Myc-Max complex, with main chain and side chain
structural parameters consistently above average (overall G valuecal reaction times for product formation were 6 hr, after which the
desired heterodimer was purified from starting materials on a Vydac 0.1).
Structure determination of the Mad-Max heterodimer was carriedsemi-preparative C4 column. Product-containing fractions were
pooled, lyophilized, dissolved in 6 M guanidine-HCl, and stored out with a 98.4% complete, 4-fold redundant native data set, with
an overall Rsym(I)  5.2% (20–2.5 A˚ resolution). The structure wasunder nitrogen gas. Oligonucleotides were purified by reverse phase
and ion exchange chromatographies. Immediately prior to crystalli- solved by molecular replacement (Navaza, 1994) utilizing the follow-
ing search model: partially refined Myc-Max heterodimer (R-free zation experiments, the purified heterodimer was refolded by serial
dialysis and excess oligonucleotide was added to the refolded het- 34.7%) with one protomer converted to polyalanine and both loop
regions deleted plus a duplex DNA fragment encompassing the Eerodimer. Reconstituted protein-DNA complexes were purified from
nonspecific aggregates and excess oligonucleotides were elimi- box and appropriate flanking nucleotides. Subsequent refinement
was performed against a 2.0 A˚ data set using O (Jones et al., 1991)nated by size exclusion chromatography.
Myc-Max/DNA cocrystals were obtained by hanging drop vapor and CNS (Bru¨nger et al., 1998). The final model consists of two
heterodimer-DNA complexes and 251 water molecules, giving andiffusion against 3–7% PEG 4000, 30% methyl pentane diol, 1 mM
cobalt hexamine chloride, 50 mM sodium cacodylate [pH 6.5] at R-factor of 26.4%, with R-free 32.4%, and rmsds for bond lengths
and angles of 0.006 A˚ and 0.94, respectively. The mean thermal15C, using a protein concentration of 10 mg/mL and a 1:1 hetero-
dimer:DNA ratio. Triclinic crystals grew in space group P1 (a  factors are 47 A˚2 for Mad and Max, 48 A˚2 for DNA, and 49 A˚2 for
solvent molecules. PROCHECK (Laskowski et al., 1993) revealed39.2 A˚, b  45.1 A˚, c  86.5 A˚,   87.9, 	  84.6, 
  71.5) with
two protein-ligand complexes/asymmetric unit and diffract to at two ( 0.7%) unfavorable (φ,) combinations in the Mad-Max com-
plex, with main chain and side chain structural parameters consis-least 1.8 A˚ resolution using synchrotron radiation. Crystals of heavy
atom derivatives were prepared with the same methods using oligo- tently above average (overall G value  0.1).
The free R-value for this structure is somewhat higher than desir-nucleotides in which 5-iodo-dUra had been substituted for Thy (Fig-
ure 1). able, which may reflect the high level of disorder in the crystals as
reflected by the high mean thermal factor values and such highMad-Max DNA cocrystals were obtained by hanging drop vapor
diffusion against 20% methyl pentane diol, 5 mM magnesium chlo- free R-values have been reported for anisotropic data of similar
resolution (Sui et al., 2001). We are, however, entirely confidentride, 50 mM sodium cacodylate [pH 6.0] at 15C, using a protein
concentration of 10 mg/mL and a 1:1 heterodimer:DNA molar ratio. of the validity of our Mad-Max cocrystal structure, which closely
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resembles the structures of all extant bHLHZ proteins (Ferre- transcriptional repression is mediated by ternary complex formation
with mammalian homologs of yeast repressor Sin3. Cell 80, 767–776.D’Amare et al., 1993; Parraga et al., 1998). Examination of difference
electron density maps showed that modeling of solvent features Baca, M., Muir, T.W., Schno¨lzer, M., and Kent, S.B.H. (1995). Chemi-
was essentially complete and stereochemical parameters for the cal ligation of cysteine-containing peptides: synthesis of a 22 kDA
model are excellent. tethered dimer of HIV-1 protease. J. Am. Chem. Soc. 117, 1881–
1887.
Protein-Protein Interactions Bao, J., and Zervos, A.S. (1996). Isolation and characterization of
A fragment of the gene encoding human Myc (corresponding to Nmi, a novel partner of Myc proteins. Oncogene 12, 2171–2176.
residues 353–434) was subcloned into pGEX-6P1 (Amersham Phar-
Benvenisty, N., Ornitz, D.M., Bennett, G.L., Sahagan, B.G., Kuo, A.,macia). A glutathione S-transferase (GST)-Myc fusion and GST alone
Cardiff, R.D., and Leder, P. (1992). Brain tumours and lymphomaswere expressed in E. coli, purified by glutathione-Sepharose chro-
in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.matography, and dialyzed against binding buffer (100 mM NaCl, 20
Oncogene 7, 2399–2405.mM HEPES [pH 7.5], 1 mM DTT, and 0.1% Triton X-100). Untagged
Blackwood, E., and Eisenman, R.N. (1991). Max: a helix-loop-helixMax (residues 22–103) was prepared and purified as described
zipper protein that forms a sequence-specific DNA-binding complex(Ferre-D’Amare et al., 1993). Mutants of Myc (Arg423→Gln;
with Myc. Science 251, 1211–1217.Arg424→Asn; Arg423→Gln/Arg424→Asn) and Max (Gln91→Arg;
Gln92→Arg; Gln91→Arg/Asn92→Arg) were generated by the poly- Brownlie, P., Ceska, T., Lamers, M., Romier, C., Stier, G., Teo, H.,
merase chain reaction using overlapping primers. GST (30 g), and Suck, D. (1997). The crystal structure of an intact human Max-
GST-Myc (30 g), and various GST-Myc mutants (30 g) were each DNA complex: new insights into mechanisms of transcriptional con-
immobilized on 50 l of glutathione-Sepharose resin (Amersham trol. Structure 5, 509–520.
Pharmacia), and unbound protein was removed by washing. Ten Bru¨nger, A.T. (1992). X-PLOR: A system for X-ray crystallography
g of wild-type or mutant Max were added to 30 l of either GST- and NMR. (New Haven: Yale University Press).
resin or GST-Myc-resin. Binding reactions were diluted with 100 l
Bru¨nger, A., Adams, P.D., Clore, G.M., Gros, P., Grosse-Kuntsleve,of binding buffer and incubated at 22C for 30 min. After thrice
R.W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N.S., and Read,washing with 100l of binding buffer, resin was harvested by centrif-
R.J. (1998). Crystallography and NMR system: a new software sys-ugation and bound proteins were visualized by gel electrophoresis.
tem for macromolecular structure determination. Acta Crystallogr.
D 54, 905–921.
Analytical Ultracentrifugation Studies
Carey, M. (1998). The enhanceosome and transcriptional synergy.Sedimentation equilibrium data were collected at 280 nm with a
Cell 92, 5–8.rotor speed of 20,000 rpm at a temperature of 20C in buffer solutions
Coller, H.A., Grandori, C., Tamayo, P., Colbert, T., Lander, E.S.,of 100 mM KCl, and 20 mM HEPES-KOH [pH 7.5] using a Beckman
Eisenman, R.N., and Golub, T.R. (2000). Expression analysis withXL-A ultracentrifuge. Solutions of the Myc-Max heterodimer were
oligonucleotide microarrays reveals that MYC regulates genes in-analyzed at three different concentrations of 0.252, 0.126, and 0.063
volved in growth, cell cycle, signaling, and adhesion. Proc. Natl.mM (corresponding to 5.34, 2.67, and 1.34 mg/ml, respectively). An
Acad. Sci. USA 97, 3260–3265.extinction coefficient of 3960 A M1 cm1 and a partial specific
volume of 0.73 cm3/g were calculated from the amino acid sequence Cole, M.D., and McMahon, S.B. (1999). The Myc oncoprotein: a
of the covalently linked Myc-Max heterodimer. Data analysis utilized critical evaluation of transactivation and target gene regulation. On-
the NONLIN program (http://www.cauma.uthscsa.edu/software). cogene 18, 2916–2924.
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R.C.,
Size Exclusion Chromatography and Croce, C.M. (1982). Human c-myc onc gene is located on the
Approximately, 300M of the heterodimer was loaded onto a Super- region of chromosome 8 that is translocated in Burkitt lymphoma
dex 75 (16/60) column (Pharmacia) and representative fractions from cells. Proc. Natl. Acad. Sci. USA 79, 7824–7827.
the elution run are shown on a Coomassie blue-stained SDS/PAGE
Dang, C.V., Dolde, C., Gillison, M.L., and Kato, G.J. (1992). Discrimi-gel. Elution volumes for four calibration standards are noted on the
nation between related DNA sites by a single amino-acid residuechromatogram.
of Myc-related basic-helix-loop-helix proteins. Proc. Natl. Acad. Sci.
USA 89, 599–602.
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